Evidence mapPaperPMID 39683399Full record

Trial reportNutrients2024

Enhancing the Impact of Individualized Nutrition Therapy with Real-Time Continuous Glucose Monitoring Feedback in Overweight and Obese Individuals with Prediabetes.

Raedeh Basiri, Lawrence J Cheskin

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Raedeh BasiriDepartment of Nutrition and Food Studies, George Mason University, Fairfax, VA 22030, USA.ORCID 0000-0002-7780-3771
Lawrence J CheskinDepartment of Nutrition and Food Studies, George Mason University, Fairfax, VA 22030, USA.ORCID 0000-0003-0262-1030

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesprediabetes is a significant risk factor for the development of type 2 diabetes, cardiovascular diseases, chronic kidney disease, and other complications. Early diagnosis of prediabetes, coupled with education on lifestyle changes that support blood glucose management, are crucial for the prevention or delay of type 2 diabetes and related complications. This study aimed to evaluate the impact of incorporating real-time feedback from continuous glucose monitoring (CGM) into individualized nutrition therapy (INT) on blood glucose control in individuals with prediabetes who are overweight or obese.

methodsparticipants (mean age ± SD: 55 ± 6 years; BMI: 31.1 ± 4.1 kg/m²) were randomly assigned to either the treatment group (

resultsthe treatment group showed a significant increase in the percentage of time spent in the target blood glucose range (

conclusionsadding CGM feedback to INT resulted in better management of blood glucose levels in overweight or obese individuals with prediabetes.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringNutrition TherapyObesityOverweightPrediabetic StateContinuous Glucose MonitoringDiabetes Mellitus, Type 2FemaleGlycemic ControlHumansMaleMiddle AgedPrecision MedicineBlood Glucoseblood glucose controlCGMdiabetesglucose CV%individualized nutrition therapynutrition educationobesityoverweightpersonalized nutritionprediabetestime in range

Identifiers

PMID39683399
PMCPMC11643611

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.